| Code | Display | Definition |
| DE40 |
Number of doses per vial |
The number of doses contained within a vial |
| DE41 |
Initial balance |
The initial quantity of vials in stock at the beginning of a specific reporting period |
| DE42 |
Closing balance |
The quantity of vials in stock at the end of a specific reporting period |
| DE43 |
Administered doses |
The quantity of vials that have been administered to clients during a specified time frame |
| DE44 |
Stock opened |
The quantity of vials that were opened during a specific period |
| DE45 |
Stock received |
The quantity of vials that have been received from external sources, such as suppliers, during a specific period |
| DE46 |
Physical count adjustment |
An adjustment made to the stock level to correct discrepancies between the recorded inventory and the actual physical count, which may be necessary owing to errors, theft or other discrepancies |
| DE47 |
Closed stock discarded |
The quantity of vials that were not opened and have been wasted or discarded, owing to expiration or other reasons, during a specific period |
| DE48 |
Closed stock discarded type |
Specific reason for the disposal of vaccine |
| DE49 |
Broken/damaged |
The vaccine is physically damaged or broken, rendering it unsuitable for use |
| DE50 |
Expired product |
The vaccine has reached its expiration date and is no longer safe or effective for use |
| DE51 |
Cold storage malfunction |
There has been a malfunction or failure in the cold storage equipment, which has led to the degradation of the vaccine |
| DE52 |
Vaccine vial monitor status change |
The vaccine vial monitor has indicated a change in status, possibly indicating that the vaccines may no longer be viable |
| DE53 |
Frozen |
The vaccine has been exposed to freezing temperatures, making it unsuitable for use as freezing can affect the integrity and efficacy of certain immunization products |
| DE18 |
Report subject area |
Location (vaccination location or place) for which the data in the report are being represented |
| DE20 |
Reporting period start date |
The start date of the reporting period for which data in the report have been included |
| DE21 |
Reporting period end date |
The end date of the reporting period for which data in the report have been included |
| DE30 |
Disaggregation group |
Indicates the overall strata or disaggregation represented in the report (e.g. by gender, by region, by age group, etc.) |
| DE31 |
By-Sex |
A disaggregation grouped by the indicator population's sex values |
| DE32 |
By-Administrative Area |
A disaggregation grouped by the indicator population's administrative regions/areas |
| DE33 |
By-Age group |
A disaggregation grouped by the indicator population's age groups |
| DE34 |
By-Dose number |
A disaggregation grouped by the indicator population's dose numbers for a specific vaccine |
| DE35 |
By-Vaccine type |
A disaggregation grouped by the indicator population's vaccine types |
| DE36 |
By-Vaccine manufacturer |
A disaggregation grouped by the indicator population's vaccine manufacturers for a specific vaccine |
| DE37 |
By-Reaction manifestation |
A disaggregation grouped by the indicator population's reaction manifestations for a specific vaccine |
| DE39 |
By-Type of reaction |
A disaggregation grouped by the indicator population's type of reaction for a specific vaccine |
| DE54 |
By-Risk and occupational group |
A disaggregation grouped by the indicator population's risk and occupational group |